Cargando…
Using a global proteomic approach to identify proteins affected by estrogen therapy
With the increase in technological capabilities for measuring biological molecules, there is a greater trend to conduct non-biased, discovery-driven studies that collect information on hundreds of molecules in a single study. The hope is that novel findings can be detected within these large dataset...
Autor principal: | Veenstra, Timothy D |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2703867/ https://www.ncbi.nlm.nih.gov/pubmed/19519954 http://dx.doi.org/10.1186/gm58 |
Ejemplares similares
-
Estrogen as therapy for breast cancer
por: Ingle, James N
Publicado: (2002) -
Proteomic and metabolomic approaches to biomarker discovery
por: Issaq, Haleem J, et al.
Publicado: (2019) -
Concentration of endogenous estrogens and estrogen metabolites in the NCI-60 human tumor cell lines
por: Xu, Xia, et al.
Publicado: (2012) -
Estrogen–progestin replacement therapy: regulatory action needed
por: Pike, Malcolm C, et al.
Publicado: (2002) -
The Extracorporeal Proteome—The Significance of Selective Protein Removal During Dialysis Therapy
por: Kratochwill, Klaus
Publicado: (2018)